Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2 Cardiovascular-Kidney-Metabolic Syndrome”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Very early researchEnrolling By InvitationNCT07209527
What this trial is testing

Truway Diagnostic Tools in Primary Care

Who this might be right for
Chronic DiseaseType 2 Diabetes Mellitus (T2DM), Obesity, OverweightHypertension+6 more
Truway Health, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Not applicableStudy completedNCT07465926
What this trial is testing

Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

Who this might be right for
Cardiovascular-kidney-metabolic SyndromeCardiovascular Disease Risk FactorKidney Disease+2 more
Chung Shan Medical University 451,036
Not applicableNot Yet RecruitingNCT07566299
What this trial is testing

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Obesity Type 2 Diabetes MellitusCardiovascular-kidney-metabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease
Chung Shan Medical University 118,805
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT04361552
What this trial is testing

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Who this might be right for
Cerebrovascular AccidentChronic Obstructive Pulmonary DiseaseChronic Renal Failure+4 more
Emory University
Not applicableStudy completedNCT06589336
What this trial is testing

SUSTAIN: Behavior Change and Nutrition Security for CKMS

Who this might be right for
Stage 2 Cardiovascular-Kidney-Metabolic SyndromeCardiovascular Disease Other
Ohio State University 106
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)WithdrawnNCT01893242
What this trial is testing

Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)

Who this might be right for
Diabetes Mellitus Type 2, Kidney Disease, Chronic
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42